Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2021-02-01

Clinical Trial Update: Systemic Lidocaine Infusion for Pain Control in Ventral Hernia [Phase 3]

View source ↗

Summary

Phase 3 trial investigating systemic lidocaine infusion for postoperative pain in ventral hernia was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lidocaine (Lidocaine)

Snippet

Sponsor: Carilion Clinic | Conditions: Post Operative Pain | Phase 3 | Status: WITHDRAWN